Skip to main content
. 2018 Oct 16;2018(10):CD009068. doi: 10.1002/14651858.CD009068.pub3

4.5. Analysis.

Comparison 4 Eplerenone versus placebo, Outcome 5 Change in size of metabolically abnormal areas of myocardium (baseline to 6 months).

Change in size of metabolically abnormal areas of myocardium (baseline to 6 months)
Study Eplerenone (mean) SD Placebo (mean) SD P value
Raman 2014 −2% 6 4% 6 0.034